Corrigendum to “Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks” [Neurochem. Int. 138 (2020) 104777]
-
Published:2023-06
Issue:
Volume:166
Page:105525
-
ISSN:0197-0186
-
Container-title:Neurochemistry International
-
language:en
-
Short-container-title:Neurochemistry International
Author:
Wahdan Sara A.,El-Derany Marwa O.,Abdel-Maged Amany E.,Azab Samar S.
Subject
Cell Biology,Cellular and Molecular Neuroscience